Biotech · Private company
Gyroscope Therapeutics Limited
Track this companyFree. Adds Gyroscope Therapeutics Limited to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- GT005Phase 2 · Age Related Macular Degeneration (AMD)ClinicalTrials.gov · fetched Nov 12, 2026
- GT005Phase 2 · Dry Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
- GT005 / Device: Orbit™ Subretinal Delivery SystemPhase 2 · Dry Age-related Macular DegenerationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent StudyPHASE2 · ENROLLING_BY_INVITATION · started Jul 12, 2022ClinicalTrials.gov NCT05481827 · fetched Nov 12, 2026
- HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005PHASE2 · TERMINATED · started Sep 28, 2020ClinicalTrials.gov NCT04566445 · fetched Nov 12, 2026
- EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005PHASE2 · TERMINATED · started Apr 26, 2019ClinicalTrials.gov NCT04437368 · fetched Nov 12, 2026
- GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)TERMINATED · started Jan 8, 2019ClinicalTrials.gov NCT03894020 · fetched Nov 12, 2026
- FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMDPHASE1_PHASE2 · TERMINATED · started Dec 17, 2018ClinicalTrials.gov NCT03846193 · fetched Nov 12, 2026